• Made multiple policy submissions to the U.S. Center for Medicare and Medicaid Services outlining solutions to improve access to generic, biosimilar and repurposed offpatent medicines, ultimately contributing to better access to medicines for America’s seniors and most vulnerable patients while improving solvency of these important government programs.